Serving the Science of Diagnostics

BBI Solutions has served the global diagnostics industry for over 50 years.

BBI Solutions has been serving the global diagnostics industry for over 50 years and is the world’s largest independent producer of immuno-diagnostics reagents.  Our core competencies include a comprehensive suite of reagents with custom development options, lateral flow development, diagnostic manufacturing services and smartphone reader technologies. Leveraging our decades of experience in all stages of diagnostic development for the right solutions the first time.



We are proud to offer a comprehensive suite of reagents for your diagnostic needs. Discover our collection of reagents covering a comprehensive range of biomarkers and applications for the IVD market, life sciences,cell culture and beyond.

Learn more
Services homepage image.jpg


Our unique combination of custom antibody development, lateral flow assay development and manufacturing services, signal enhancement technology and our smartphone reader technology are shaping the future of lateral flow. Our partnership approach allows you to work with one company to reach your assay goals.

Learn more


BBI Solutions are revolutionising point of care testing. Our patented Novarum™️ technology transforms a smartphone into a diagnostic test reader, empowering users to read and share the results of rapid tests from the point of care.

Our highly trained team will work with you to develop a bespoke mobile app that meets your specific test needs. Data is then shared to a secure server for evaluation.

Accuracy, connectivity and ease of use make the Novarum™️ smartphone diagnostic platform invaluable for a variety of sectors, including medical, veterinary, defence, agricultural and environmental testing..

Learn more

BBI Solutions Brands


The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.


Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.


Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox